GUCY1A1 Antikörper

Produktnummer ABIN7604952

Dieser Kaninchen Monoklonal Antikörper erkennt spezifisch GUCY1A1 in WB. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für GUCY1A1 Antikörper (ABIN7604952)

Target: GUCY1A1 (Guanylate Cyclase 1 Soluble Subunit Alpha (GUCY1A1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser GUCY1A1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Klon: 25G96

Produktdetails anti-GUCY1A1 Antikörper

Verwendungszweck: Anti-GCYA3 Rabbit Monoclonal Antibody

Produktmerkmale: Anti-GCYA3 Rabbit Monoclonal Antibody (ABIN7604952). Tested in WB application. This antibody reacts with Human.

Aufreinigung: Affinity-chromatography

Immunogen: A synthesized peptide derived from human GCYA3

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:500-1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.

Details zu GUCY1A1

Target: GUCY1A1 (Guanylate Cyclase 1 Soluble Subunit Alpha (GUCY1A1))

Andere Bezeichnung: GUCY1A1

Hintergrund:

Synonyms: Red fluorescent protein eqFP611,GFP-like chromoprotein,

Tissue Specificity: Highly and selectively expressed by undifferentiated rather than differentiated embryonic stem cells (ESC). Levels rapidly diminish as soon as ESC's differentiate (at protein levels). Expressed in almost all epithelial cell membranes but not on mesodermal or neural cell membranes. Found on the surface of adenocarcinoma. .

Molekulargewicht: 73 kDa

UniProt: Q02108

Pathways: Myometrial Relaxation and Contraction